What the FDA labels say about taking them together
Dobutamine and linezolid
Linezolid's FDA label of June 19, 2026 names dobutamine in its warnings and precautions section; the dobutamine labels PlainMeds reads (2) do not name linezolid. The linezolid label: “Elevation of Blood Pressure Unless patients are monitored for potential increases in blood pressure, linezolid should not be administered to patients with uncontrolled hypertension, pheochromocytoma, thyrotoxicosis …”
Check it at the source: the dobutamine FDA label on DailyMed (effective June 3, 2026, Hospira, Inc.); the linezolid FDA label on DailyMed (effective June 19, 2026, Hospira, Inc.).
What does the dobutamine label say about linezolid?
Dobutamine's label (effective June 3, 2026) and its 1 other brand-application label do not name linezolid in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Dobutamine in Dextrose), Hospira, Inc., effective June 3, 2026 (SPL set 9943a961-3b50-4847-8a84-d8414ce38daa), via openFDA; the full label on DailyMed
What does the linezolid label say about dobutamine?
Linezolid label, warnings and precautionsElevation of Blood Pressure Unless patients are monitored for potential increases in blood pressure, linezolid should not be administered to patients with uncontrolled hypertension, pheochromocytoma, thyrotoxicosis and/or patients taking any of the following types of medications: directly and indirectly acting sympathomimetic agents (e.g., pseudoephedrine), vasopressive agents (e.g., epinephrine, norepinephrine), dopaminergic agents (e.g., dopamine, dobutamine) [ see Drug Interactions (7) and Clinical Pharmacology (12.3) ].
Source: FDA drug label (Linezolid), Hospira, Inc., effective June 19, 2026 (SPL set c401f1a8-cc37-461b-bfef-f2e156629bf8), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Dobutamine | Linezolid | |
|---|---|---|
| Labeled for | n/a | Bacterial infections |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | n/a | $1.44 per tablet 600 mg tablet |
| Shortage now | In shortage | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once